Last updated: April 2026
Futur Health vs Willow: Compare GLP-1 Programs & Pricing
Side-by-side Futur Health and Willow: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.
Futur Health and Willow are two established telehealth providers offering GLP-1–based weight‑management programs. This article compares Futur Health vs Willow to help you identify which best fits your goals, budget, and preferred level of clinical support.
Visit Futur Health
Explore Willow
Futur Health vs Willow: Quick Overview
| Provider | Semaglutide | Tirzepatide | Promo | Membership |
|---|---|---|---|---|
| Futur Health | $299.00 | $399.00 | (Code: ) | $99 — Yes |
| Willow | $299.00 | $399.00 | Best for Oral and Injectable (Code: ) | — No |
Futur Health vs Willow: Medical Process & Accessibility
Futur Health emphasizes a streamlined intake: a digital questionnaire, a brief video visit, and same‑day clinician approval when possible. Once approved, the prescription is sent to a U.S.-based compounding pharmacy that ships directly to your door. The entire workflow complies with FDA telehealth guidance and state medical board regulations.
Willow takes a slightly longer onboarding route, incorporating an initial lab order (optional) and a two‑step clinician review. After the first approval, Willow schedules regular virtual follow‑ups—typically every 4‑6 weeks—to fine‑tune dosage, monitor side effects, and ensure ongoing FDA‑compliant prescribing practices.
Futur Health vs Willow: Pricing Comparison
Futur Health starts semaglutide at $299.00 and tirzepatide at $399.00. A $99 monthly membership fee unlocks unlimited virtual visits, priority pharmacy processing, and access to a private patient portal. There is no separate promo code listed at this time, but the base price already reflects the company’s “no‑hidden‑fees” model.
Willow also lists semaglutide at $299.00 and tirzepatide at $399.00. Willow does not charge a membership fee, which can make the overall cost appear lower for patients who need fewer follow‑up visits. The promotional tagline “Best for Oral and Injectable” highlights that Willow offers both injectable GLP‑1s and an FDA‑approved oral formulation of semaglutide (Rybelsus®) when clinically appropriate.
Futur Health vs Willow: Clinical Oversight & Support
Both platforms provide access to board‑certified endocrinologists, obesity medicine specialists, or nurse practitioners licensed in the patient’s state. Futur Health’s support model is built around rapid response—patients often receive a prescription within 24‑48 hours of the initial consult. Willow’s model favors ongoing relationship building, with a dedicated care coordinator who tracks weight trends, labs, and side‑effect profiles over the course of treatment.
Book a Consultation with Futur Health
Willow’s clinicians also have prescribing authority for adjunct medications such as metformin or appetite‑suppressing agents, offering a more comprehensive pharmacologic toolbox for patients with complex metabolic needs.
Schedule a Willow Consultation
Futur Health vs Willow: Medication Quality & Safety
Both providers dispense compounded GLP‑1 medications from FDA‑registered pharmacies that follow USP USP standards. While the compounds are not the brand‑name products (e.g., Wegovy® or Mounjaro®), they contain the same active ingredients and are produced under strict quality‑control protocols. Each prescription is reviewed by a licensed clinician and must meet state telehealth prescribing rules before the pharmacy fills the order.
Futur Health vs Willow: Customer Experience
Patient testimonials on independent forums frequently cite Futur Health’s “fast, affordable, and hassle‑free” experience. Users appreciate the transparent pricing and the single‑payment membership that eliminates surprise charges.
Willow’s reviewers often mention the “personal touch” of regular check‑ins and the ability to discuss oral versus injectable options. Some patients note the slightly longer wait for the first prescription, but they value the deeper clinical engagement that can lead to better long‑term adherence.
Futur Health vs Willow: Final Verdict
If you prioritize low upfront cost, rapid onboarding, and a straightforward membership structure, Futur Health is likely the better fit. Its pricing model is transparent, and the $99 monthly fee bundles all virtual visits, making budgeting simple.
Conversely, if you want ongoing clinical guidance, the option to switch between oral and injectable semaglutide, and a platform that emphasizes dose optimization, Willow may be the superior choice. The lack of a membership fee can also be attractive for patients who expect fewer virtual appointments.
Disclaimer
This article is for informational purposes only and does not constitute medical advice. ExploreProviders may receive affiliate commissions at no cost to you. Always consult a licensed clinician before beginning any medical treatment.
Recommended next step
Review the latest provider details before you decide.